Twist Bioscience Corporation employees and revenue per employee

TWST · Biotechnology · $7.04B market cap

Twist Bioscience Corporation had 979 employees at the end of fiscal Sep 2025, up 6.1% from a year earlier. Revenue for the year was $377M, up 20.3% from a year earlier, or $385K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

979

+6.1% YoY

Revenue

$377M

+20.3% YoY

Revenue / employee

$385K

Peer median $457K

Rank in industry

65 of 110

Biotechnology

Open roles

55

56 per 1,000 staff

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Sep 2018
07961591'18'19'20'21'22'23'24'25Revenue 1481Staff 1440

Hover a year for the numbers.

TWST employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Sep 2025979$377M$385K+6.1%+20.3%
Sep 2024923$313M$339K+329.3%+27.7%
Sep 2023215$245M$1.14M-78.3%+20.4%
Sep 2022989$204M$206K+51.7%+53.8%
Sep 2021652$132M$203K+24.2%+46.9%
Sep 2020525$90.1M$172K+26.8%+65.7%
Sep 2019414$54.4M$131K+508.8%+113.9%
Sep 201868$25.4M$374K——

Open roles on its job board: 55 (56 per 1,000 staff, against its latest annual headcount), as of 2026-11-20. Tracked since 2026-10-03. No 90 day change yet.

Employees, last six fiscal years
525'20652'21989'22215'23923'24979'25
Revenue per employee, last six fiscal years
$172K'20$203K'21$206K'22$1.14M'23$339K'24$385K'25

Twist Bioscience Corporation against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
INVA
Innoviva, Inc.
159$425M$2.67MHiring ahead
RIGL
Rigel Pharmaceuticals, Inc.
172$294M$1.71MEfficient growth
CRMD
CorMedix Inc.
191$312M$1.63MEfficient growth
KRYS
Krystal Biotech, Inc.
295$389M$1.32MEfficient growth
TARS
Tarsus Pharmaceuticals, Inc.
370$451M$1.22MEfficient growth
ARQT
Arcutis Biotherapeutics, Inc.
354$376M$1.06MEfficient growth
TVTX
Travere Therapeutics, Inc.
497$491M$987KEfficient growth
XERS
Xeris Biopharma Holdings, Inc.
435$292M$671KEfficient growth
TWST
Twist Bioscience Corporation
979$377M$385KEfficient growth
Every Healthcare company

Questions about Twist Bioscience Corporation

How many employees does Twist Bioscience Corporation have?
Twist Bioscience Corporation reported 979 employees for the fiscal year ending Sep 2025, in the annual report it filed on November 17, 2025. That is up 6.1% from a year earlier.
What is Twist Bioscience Corporation's revenue per employee?
Twist Bioscience Corporation brought in $377M of revenue in fiscal Sep 2025, which is $385K per employee. That ranks 65 of 110 companies we track in Biotechnology, where the median is $457K.
Is Twist Bioscience Corporation hiring?
Twist Bioscience Corporation's public job board listed 55 open roles on November 20, 2026, about 56 per 1,000 staff.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare TWST with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Twist Bioscience Corporation's annual reports (Form 10-K), latest filed November 17, 2025. This is data, not a recommendation to buy or sell TWST.